Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Government of the United States, as represented by the Secretary of the Army”

23 pharma patents match "The Government of the United States, as represented by the Secretary of the Army" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 23
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 23 pharmaceutical patents matching "The Government of the United States, as represented by the Secretary of the Army" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

23 results for “The Government of the United States, as represented by the Secretary of the Army” · 30,257 patents in full index Clear search

  1. US 12364745

    Immunogenicity of a CpG-adjuvanted recombinant plague vaccine

    The Government of the United States, as represented by the Secretary of the Army · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted

  2. US 12292441

    Recombinant Acinetobacter baumannii strain AB5075

    The Government of the United States, as represented by the Secretary of the Army · Granted May 6, 2025 · Expires May 1, 2045

    granted

  3. US 11963959

    Inhibitors for coronavirus

    The Government of the United States, as represented by the Secretary of the Army · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted

  4. US 11884718

    Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination

    The Government of the United States, as represented by the Secretary of the Army · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted

  5. US 11865111

    Antiviral drugs targeting the N-terminal domain (NTD) of the coronavirus spike receptor binding domain (RBD)

    The Government of the United States, as represented by the Secretary of the Army · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted

  6. US 11744828

    Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects

    The Government of the United States, as represented by the Secretary of the Army · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  7. US 11691992

    Oxaborole analogs and uses thereof

    The Government of the United States, as represented by the Secretary of the Army · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted

  8. US 11583578

    Plasmodium falciparum recombinanr xiexumapoeozoite protein compositions and method for vaccine delivery

    The Government of the United States, as represented by the Secretary of the Army · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  9. US 11459308

    Broad spectrum inhibitors of filoviruses

    The Government of the United States, as represented by the Secretary of the Army · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted

  10. US 11440951

    Therapeutic antibodies to Marburg virus

    The Government of the United States, as represented by the Secretary of the Army · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted

  11. US 11389400

    Aerosilization of stem cells or stem cell derivatives for pulmonary delivery

    The Government of the United States, as represented by the Secretary of the Army · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted

  12. US 11345653

    Compositions and methods for reactivating cholinesterases

    The Government of the United States, as represented by the Secretary of the Army · Granted May 31, 2022 · Expires May 26, 2042

    granted

  13. US 11155834

    Sin Nombre virus full-length M segment-based DNA vaccines

    The Government of the United States, as represented by the Secretary of the Army · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  14. US 11053285

    Nucleic acids encoding human immunodeficiency virus type 1 (HIV-1) N-terminal deleted gp120 immunogens and methods of use

    The Government of the United States, as represented by the Secretary of the Army · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  15. US 11033615

    Zika virus vaccine and methods of production

    The Government of the United States, As Represented by the Secretary of the Army Fort Detrick, Maryland · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  16. US 11013791

    NYVAC-based plasmodium malaria vaccine

    The Government of the United States, as represented by the Secretary of the Army · Granted May 25, 2021 · Expires May 20, 2041

    granted

  17. US 10888558

    Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

    The Government of the United States, as represented by the Secretary of the Army · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted

  18. US 10875907

    Filovirus antibody

    The Government of the United States, as represented by the Secretary of the Army · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  19. US 10548946

    Therapeutic compositions for neutralizing type I interferons, and methods of use

    The Government of the United States, as represented by the Secretary of the Army · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted

  20. US 10525123

    Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment

    The Government of the United States, as represented by the Secretary of the Army · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted

  21. US 10443073

    Sin Nombre virus full-length M segment-based DNA vaccines

    The Government of the United States, as represented by the Secretary of the Army · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  22. US 10434167

    Non-toxic adjuvant formulation comprising a monophosphoryl lipid A (MPLA)-containing liposome composition and a saponin

    The Government of the United States, as represented by the Secretary of the Army · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

  23. US 10435461

    Therapy for filovirus infection

    The Government of the United States, as represented by the Secretary of the Army · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.